GlassScriptPhysician profile
Rishi Verma Kumar
NPI 1114970415
$7,783.99
in general payments reported to CMS, 2019-2025
37 companies · $1,343 in 2025
The $1,343 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,609 · 2020: $178 · 2021: $513 · 2022: $1,325 · 2023: $1,024 · 2024: $1,792 · 2025: $1,343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,087 · Entertainment: $72.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,087.24 |
| Entertainment | $72.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $821.92 | 2019-2025 | Clareon Panoptix Pro, Clareon, Rocklatan |
| Sight Sciences, INC. | $516.49 | 2021-2024 | Omni Surgical System, Tearcare System |
| Tarsus Pharmaceuticals, INC. | $502.44 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $474.43 | 2022-2025 | Vyzulta, Miebo, Scoutpro Osmolarity System |
| Glaukos Corporation | $472.46 | 2019-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Harrow Eye, LLC | $416.76 | 2024-2025 | Vevye, Iheezo, Triesence |
| Amgen INC. | $403.52 | 2025 | Tepezza, Uplizna |
| Johnson & Johnson Surgical Vision, INC. | $396.74 | 2024-2025 | Tecnis Iol, Tecnis Simplicity |
| Ocular Therapeutix, INC. | $374.30 | 2021-2025 | Dextenza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $350.11 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $269.37 | 2019-2021 | |
| Shire North American Group INC | $255.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $218.53 | 2019-2022 | |
| Allergan, INC. | $175.51 | 2019-2022 | |
| Abbvie INC. | $162.12 | 2022-2024 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $147.81 | 2019-2022 | |
| Abiomed | $145.77 | 2025 | |
| Astellas Pharma US INC | $140.68 | 2024-2025 | Izervay, Vyloy |
| Pfizer INC. | $135.00 | 2019 | |
| Oyster Point Pharma, INC. | $134.74 | 2022-2024 | Tyrvaya |
| Ivantis, INC | $134.47 | 2019 | |
| Genentech USA, INC. | $121.86 | 2023 | Vabysmo |
| Kala Pharmaceuticals, INC. | $119.70 | 2019 | |
| Ellexiscience | $119.70 | 2019 | |
| Merck Sharp & Dohme LLC | $114.83 | 2019 | |
| Silk Road Medical, INC. | $104.64 | 2021 | |
| Biotissue Holdings INC. | $99.14 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $88.80 | 2022 | |
| New World Medical,INC. | $75.48 | 2022-2025 | Streamline, Kahook Dual Blade, Via360 |
| Optos, INC. | $72.59 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Iridex Corporation | $50.00 | 2019 | |
| Dompe US, INC. | $45.95 | 2022-2025 | Oxervate |
| Rayner Intraocular Lenses Limited | $45.47 | 2023 | Rayone Aspheric, Omidria, Rayone Emv |
| Quidel Corporation | $32.44 | 2023 | |
| Rxsight INC | $16.32 | 2022 | |
| Lkc Technologies, INC. | $14.49 | 2024 | |
| Tearlab Corp | $14.41 | 2024 | Scoutpro Osmolarity System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rishi Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.